Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?
/in Dendritic Cells, International Publications /von 2018-11-23 / Vaccines (Basel) 2018 Nov;6(4)Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-11-21 / Clin Transl Oncol 2019 Jun;21(6):774-780Kongress der Deutschen Gesellschaft für Hyperthermie stellt neuste Ergebnisse vor
/0 Kommentare/in Externe Meldungen /von IOZKOncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-11-14 / Clin Transl Med 2018 Nov;7(1):35Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth
/in Cervical Cancer, Hyperthermia, International Publications, Ovarian Cancer /von 2018-11-14 / Int J Hyperthermia 2019;36(1):9-20The Dilemma of Cure and Damage in Oligodendroglioma: Ways to Tip the Balance Away from the Damage
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-11-12 / Cancers (Basel) 2018 Nov;10(11)First in vitro evidence of modulated electro-hyperthermia treatment performance in combination with megavoltage radiation by clonogenic assay
/in Hyperthermia, International Publications /von 2018-11-09 / Sci Rep 2018 Nov;8(1):16608Case Report of a Patient with Breast Metastasis from Gastric Cancer Treated with Paclitaxel and Ramucirumab Plus Regional Hyperthermia
/in Gastric Cancer, Hyperthermia, International Publications /von 2018-11-01 / Anticancer Res. 2018 Nov;38(11):6561-6564
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution